The Hsp90 chaperone complex - A potential target for cancer therapy?

World Journal of Gastroenterology

Volumn 5, Issue 3, 1999, Pages 195-198

  Darimont, Beatrice D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000976965     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v5.i3.195     Document Type: Article

References (60)

1. Hartl FU. Molecular chaperones in cellular protein folding. Nature, 1996;381:571-579
2. Csermley P, Schnaider T, Söti C, Prohászka Z, Nardai G. The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review. Pharmacol Ther, 1998; 79: 129-168
3. Csermely P. Proteins, RN'As, chaperones and enzyme evolution; a folding perspective. Trends Biochem Sci., 1997;22:147-149
4. Rutherford SL, Lindquist S. Hsp90 as a capacitor for morphological evolution. Nature, 1998;396:336-342
5. Welch WJ. Mammalian stress response: cell physiology, structure/ function of stress proteins, and implication for medicine and disease. Physiol Rev, 1992;72:1063- 1081
6. Burdon RH. Heat shock proteins in relation to medicine. Mol Aspects Med, 1993;14:83-165
7. Jindal S. Heat shock proteins: applications in health and disease. Trends Biotechnol , 1996;14:17-20
8. Brooks DA. Protein processing: a role in the pathophysiology of genetic disease. FEBS Lett, 1997;409:115-120
9. Scheibel T, Buchner J. The Hsp90 complex - a super-chaperone machine as a novel drug target. Biochem Pharmacol , 1998; 56: 675-682
10. Pratt WB. The Hsp90-based chaperone system: involvement in signal transduction from a variety of hormone and growth factor receptors. Proc Soc Exper Biol Med, 1998;217:420-434
11. Scheibel T, Buchner J. The Hsp90 family: an overview. In:Gething MJ, ed. Guidebook to molecular chaperones and protein-catalyses. Oxford: Oxford University Press, 1997:147-151
12. Krone PH, Sass JB. Hsp90α and Hsp90β genes are present in the zebrafish and are differentially regulated in developing embryos. Biochem Biophys Res Comm, 1994;204:746-752
13. Gupta RS. Phylogenetic analysis of the 90kD heat shock family of protein sequences and an examination of the relationship among animals, plants, and fungi species. Mol Biol Evol , 1995; 12: 1063-1073
14. Nair SC, Toran EJ, Rimerman RA, Hjermstad S, Smithgall TE, Smith DF. A pathway of multi-chaperone interactions common to diverse regulatory proteins-estrogen receptor, fes tyrosine kinase, heat shock transcription factor, HSF1, and the aryl hydrocarbon receptor. Cell Stress Chaperones, 1996;1:237-250
15. Johnson JL, Craig EA. Protein folding in vivo: unraveling complex pathways. Cell, 1997;90:201-204
16. Nathan DF, Vos MH, Lindquist S. In vivo function of the Saccharomyces cerevisiae Hsp90 chaperone. Proc Natl Acad Sci USA, 1997;94:12949-12956
17. Smith DF, Toft DO. Steroid receptors and their associated proteins. MolEndo, 1993;7:4-11
18. Bohen SP, Yamamoto KR. Modulation of steroid receptor signal transduction by heat-shock proteins. In: The biology of heat-shock proteins and molecular chaperones. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1994:313-334
19. Pratt WB, Toft DO. Steroid receptor interactions with heat-shock protein and immunophilin chaperones. Endo Rev, 1997;18:306-360
20. Pratt WB. The role of the Hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase. Annu Rev Pharmacol Toxicol , 1997;37:297-326
21. Holley SJ, Yamamoto KR. A role for Hsp90 in retinoid receptor signal transduction. Mol Biol Cell, 1995;6:1833-1842
22. Pongratz I, Mason GG, Poellinger L. Dual roles of the 90-kDa heat shock protein Hsp90 in modulating functional activities of the dioxin receptor. Evidence that the dioxin receptor functionally belongs to a subclass of nuclear receptors which require Hsp90 both for ligand binding activity and repression of intrinsic DNA binding activity. J Biol Chem, 1992;267:13728-13734
23. Picard D, Khurshed B, Garabedian MJ, Fortin MG, Lindquist S, Yamamoto KR. Reduced levels of Hsp90 compromise steroid receptor action in vivo. Nature, 1990;348:166-168
24. Bohen SP, Yamamoto KR. Isolation of Hsp90 mutants by screening for decreased steroid function. Proc Natl Acad Sci USA, 1993;11424-11428
25. Nathan DF, Lindquist S. Mutational analysis of Hsp90 function; interactions with a steroid receptor and a protein kinase. Mol Cell Biol , 1995;15:3917-3925
26. DeFranco DB, Ramakrishnan C, Tang Y. Molecular chaperones and subcellular trafficking of steroid receptors. J Steroid Biochem Molec Biol , 1998;65;51-58
27. Xu Y, Lindquist S. Heat-shock protein Hsp90 governs the activity of pp60v-src kinase. Proc Natl Acad Sci USA, 1993;90:7074-7078
28. van der Straten A, Rommel C, Dickson B, Hafen E. The heat shock protein 83 ( Hsp83 ) is required for Raf-mediated signalling in Drosophila. EMBO J, 1997; 16:1961-1969
29. Uma S, Hartson SD, Chen JJ, Matts RL. Hsp90 is obligatory for the hemeregulated eIF-2α kinase to acquire and maintain an activable conformation. J Biol Chem , 1997;272:11648-11656
30. Miyata Y, Yaharal. The 90-kDa heat shock protein, Hsp90, binds and protects casein kinase II from self-aggregation and enhances its kinase activity. J Biol Chem , 1992;267:7042-7047
31. Stancato LF, Silverstein AM, Owens-Grillo JK, Chow YH, Jove R, Pratt WB. The Hsp90-binding antibiotic geldanamycin decreases Raf levels and epidermal growth factor signaling without disrupting formation of signaling complexes or reducing the specific enzymatic activity of Raf kinase. J Biol Chem , 1997;272:4013-4020
32. Dai K, Kobayashi R, Beach D. Physical interaction of mammalian CDC37 with CDK4. J Biol Chem , 1996;271:22030-22034
33. Stephanova L, Leng X, Parker SB, Harper JW. Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4. Genes Dev, 1996;10:1491-1502
34. Aligue R, Akhavan-Niak H, Russell P. A role for Hsp90 in cell cycle control; wee 1 tyrosine kinase requires interaction with Hsp90. EMBO J, 1994;13:6099-6106
35. Kimura Y, Rutherford SL, Miyata Y, Yahara I, Freeman BC, Yue L, Morimoto RI, Lindquist S. Cdc37 is a molecular chaperone with specific functions in signal transduction. Genes Dev, 1997;11:1775-1785
36. Le Bihan S, Marsaud V, Mercier Bodard C, Baulieu EE, Mader S, White JH, Renoir JM. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin-and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells. Mol Endo, 1998;12:986-1001
37. Sato N, Torigoe T. The molecular chaperones in cell cycle control. Annals New York Acad Sci , 1998;851:61 -66
38. Galea-Lauri J, Latchman DS, Katz DR. The role of the 90-kDa heat shock protein in cell cycle control and differentiation of the monoblastoid cell line U937. Exp Cell Res , 1996;226:243-254
39. Sepehmia B, Paz IB, Dasgupta G, Momand J. Heat shock protein 84 forms a complex with mutant p53 protein predominantly within a cytoplasmic compartment of the cell. J Biol Chem , 1996;271:15084-15090
40. Jerome V, Vourc'h C, Baulieu EE, Catelli MG. Cell cycle regulation of the chicken Hsp90a expression. Exp Cell Res, 1993;205:44-51
41. Ferrarini M, Heltai S, Zocchi MR, Rugarli C. Unusual expression and localization of heat-shock proteins in human tumor cells. Int J Cancer, 1992;51:613-619
42. Yufu Y, Nishimura J, Nawata H. High constitutive expression of heat shock protein 90a in human acute leukemia cells. Leuk Res, 1992;16:597-605
43. Franzen B, Linder S, Alaiya AA, Eriksson E, Fujioka K, Bergman AC, Jornvall H, Auer G. Analysis of polypeptide expression in benign and malignant human breast lesions. Electrophoresis, 1997; 18:582-587
44. Nanbu K, Konishi I, Komatsu T, Mandai M, Yamamoto S, Kuroda H, Koshiyama M, Mori T. Expression of heat shock proteins HSP70 and Hsp90 in endometrial carcinomas. Correlation with clinicopathology, sex steroid receptor status, and p53 protein expression. Cancer, 1996;77:330-338
45. Liu XL, Xiao B, Yu ZC, Guo JC, Zhao QC, Xu L, Shi YQ, Fan DM. Down-regulation of Hsp90 could change cell cycle distribution and increase drug sensitivity of tumor cells. WJG , 1999;199-208
46. Luparello C, Noel A, Pucci-Minafra I. Intratumoral heterogeneity for Hsp90 beta mRNA levels in a breast cancer cell line. DNA Cell Biol , 1997; 16: 1231-1236
47. Cardenas ME, Sanfridson A, Cutler NS, Heitman J. Signal-transduction cascades as targets for therapeutic intervention by natural products. Trends Biotechn , 1998;16:427-433
48. Stebbins CE, Russo AA, Schneider C, Rosen N, Hartl FU, Pavletich NP. Crystal structure of an Hsp90-geldanamycin complex; targeting of a protein chaperone by an antitumor agent. Cell, 1997;898:239-250
49. Uehara Y, Murakami Y, Suzukake-Tsuchiya K, Moriya Y, Sano H, Shibata K, Omura S. Effects of herbimycin derivatives on src oncogene function in relation to antitumor activity. J Antiobiot (Tokyo), 1988; 41:831-834
50. Sharma SV, Agatsuma T, Nakano H. Targeting of the protein chaperone, Hsp90, by the transformation suppressing agent, radicicol. Oncogene, 1998;16:2639-2645
51. Roe SM, Prodromou C, O'Brian R, Ladbury JE, Piper PW, Pearl LH. Structural basis for the inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. J Med Chem , 1999;42:260-262
52. Bertram J, Palfner K, Hiddemann W, Kneba M. Increase of P-glycoprotein-mediated drug resistance by Hsp90 beta. Anti-Cancer Drugs, 1996;7:838-845
53. Persidis A. Cancer multidrug resistance. Nature Biotech , 1999;17:94-95
54. Bradshaw DM, Arceci RJ. Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance. J Clinic Oncol, 1998; 16:3674-3690
55. Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, Ross DD. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA, 1998; 95: 15665-15670
56. Volm M. Multidrug resistance and its reversal. Anticancer Res, 1998; 18:2905-2917
57. Nooter K, Stoter G. Molecular mechanisms of multidrug resistance in cancer chemotherapy. Pathol Res Practice, 1996;192:768-780
58. Multhoff G, Botzler C, Issels R. The role of heat shock proteins in the stimulation of an immune response. Biol Chem , 1998;379:295-300
59. Campbell FA, Redmond HP, Bouchier-Hayes D. The role of tumor rejection antigens in host antitumor defense mechanisms. Cancer, 1995;75:2649-2655
60. Prodromou C, Roe SM, O'Brien R, Ladbury JE, Piper PW, Pearl LH. Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone. Cell, 1997;90:65-75